Delivery Order SPE2DB24D1104-SPE2DB24FXZN6

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of methylphenidate extended-release 54 mg tablets. The Firm Fixed Price delivery order, valued at $1,581.65, has an ultimate completion date of July 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 36 mg methylphenidate extended-release tablets in 100-count bottles. The $2,242.10 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) on May 21, 2024, with a completion date of May 22, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,734.70 firm-fixed-price delivery order is for the supply of 4,564,298,148 units of Methylphenidate Extended Release 27 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of methylphenidate extended-release 18 mg tablets in 100-count bottles. The $1,649.14 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) and has a completion date of June 13, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
This federal contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of methylphenidate extended-release 27 mg tablets in 100 count bottles. The total ceiling value of the delivery order is $2,282.40, with a firm fixed price and an ultimate completion date of October 31, 2024. This contract is not designated as a set-aside and represents an open competition award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,466.89 firm fixed price Delivery Order is for the supply of 4,564,735,331 methylphenidate extended-release 36 mg tablets, to be delivered by May 29, 2024. The contract is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides methylphenidate extended-release tablets for the Defense Logistics Agency (DLA). The $2,327.56 firm fixed-price delivery order has a completion date of January 25, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle for supplying a wide range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order contract for the supply of 4,564,933,079 units of Methylphenidate Extended Release 36 mg tablets in 100-count bottles. The $1,239.24 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of June 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $3,696.24, is a firm fixed price delivery order for the supply of 4,563,943,982 methylphenidate extended-release 36 mg tablets in 100-count bottles. The contract has a performance period through March 13, 2024 and does...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,048,127 units of methylphenidate extended-release 36 mg tablets in 100-count bottles. The contract has a ceiling value of $1,306.84 and an ultimate completion date of July 2, 2024. It is a delivery order contract with a firm fixed price pricing type, awarded by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen holds a larger Indefinite Delivery Contract...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FXZN6
    Delivery Order

This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, to supply methylphenidate extended-release 27 mg tablets in 100-count bottles. The Firm Fixed Price delivery order, valued at $4,382.85, has a completion date of June 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This order is not designated as a set-aside contract.

Generated 9/23/24, 9:45 AM